Daily pill can double survival time for world’s deadliest cancer, trial shows

A daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, according to a clinical trial hailed as a 'gamechanger' by experts. Pancreatic cancer is described as the world’s deadliest cancer with few effective treatments.